While my primary aim is to listen to clients, thereby increasing their level of satisfaction, I look forward to contributing to a company that is furthering the significant diagnostic advances leading to a more personalized treatment for cancer patients.
Princeton, NJ (PRWEB) September 29, 2012
NovoPath, Inc., a leader in Anatomic Pathology Best-of-Breed Software Solutions, is pleased to announce the addition of Tami Abell to their team.
Tami, a seasoned professional, will hit the ground running as she brings over two decades of hands-on senior level management expertise, backed by a technical background. Her qualifications include a successful track record in healthcare marketing and sales, and her extensive experience in the Healthcare Information Technology sector translates to a comprehensive understanding of this sophisticated arena. For the last 10 years, Tami has drilled down, focusing on the anatomic pathology market – specifically laboratory information systems and software.
As Account Manager, Tami will be contributing to the growth of the organization by concentrating on enrichment of NovoPath client satisfaction. In her new role, Tami will act as a conduit to customers when she designs and implements NovoPath’s new User Group Program, and as liaison to the New Product Development team – translating client needs into viable product enhancements and solutions.
When asked about her new assignment, Tami replied, “I joined NovoPath because I wanted to be part of a team actively involved in driving the Anatomic Pathology market. While my primary aim is to listen to clients, thereby increasing their level of satisfaction, I look forward to contributing to a company that is furthering the significant diagnostic advances leading to a more personalized treatment for cancer patients.”
About NovoPath, Inc.:
NovoPath, Inc. develops and markets software solutions for the Anatomic Pathology Laboratory market segment that includes local, regional, national, in-house laboratories as well as community and university teaching hospitals and medical centers. Since the release of its flagship product in 1999, NovoPath, Inc. has focused exclusively on Anatomic Pathology. NovoPath's mission is to provide unique and unparalleled solutions and services to all aspects of the Anatomic Pathology sector in a way that improves workflow, reduces the probability of human error, ensures results accuracy for greater patient safety, protects patient confidentiality, and above all, produces more precise and informative diagnostic outcomes. More information is available at http://www.NovoPath.com.